Activating soluble guanylyl cyclase attenuates ischemic kidney damage

2024/11/19 by Falk‐Bach Lichtenberger, Falk-Bach Lichtenberger, Minze Xu +15 · 1 voice · 1 citation
Biochemistry, Genetics and Molecular Biology · Medicine · #Acute Kidney Injury Research #Biochemical Acid Research Studies #Coenzyme Q10 studies and effects

paper · doi:10.1016/j.kint.2024.10.025

openalex publication_date 2024/11/19 · crossref created 2024/11/19 · crossref issued 2025/03/01 · crossref published 2025/03/01 · crossref published-print 2025/03/01 · openalex created_date 2025/10/10 · crossref deposited 2026/05/12 · crossref indexed 2026/05/14 · openalex updated_date 2026/07/30

Citations

• Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

Cited by

• Soluble guanylate cyclase as a direct target for pharmacologic mitigation of chronic kidney disease

Discussions

• Activating soluble guanylyl cyclase attenuates ischemic kidney damage doi.org/10.1016/j.kint.2024.10.025 #OpenAccess #AKI #acutekidneyinjury #CKD #chronickidneydisease [bsky, 3 points, 0 comments]